KILITCH DRUGS Share Price
KILITCH DRUGS Share Price Today
As of 5 Jul 2026, KILITCH DRUGS share price is ₹187.50. The stock opened at ₹197.95, compared to its previous close of ₹196.99. During today's trading session, KILITCH DRUGS share price moved in the range of ₹187.15 to ₹197.95, with an average price of ₹192.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹117.25 and a high of ₹250.00. On the performance front, KILITCH DRUGS share price has increased by 4.58% over the last six months and is down 15.07% on a year-on-year basis.
KILITCH DRUGS Returns Calculator
KILITCH DRUGS Shareholder Returns
KILITCH DRUGS Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
KILITCH DRUGS Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹198.32 | ₹154.37 | ₹139.60 | ₹114.23 |
| Other Income | ₹11.16 | ₹4.48 | ₹2.92 | ₹2.91 |
| Total Revenue | ₹209.48 | ₹158.85 | ₹142.52 | ₹117.14 |
| Total Expenses | ₹175.00 | ₹139.50 | ₹130.50 | ₹107.53 |
| Profit Before Tax | ₹34.47 | ₹19.35 | ₹12.01 | ₹9.61 |
| Tax | ₹9.53 | ₹5.78 | ₹3.73 | ₹3.40 |
| Profit After Tax | ₹24.94 | ₹13.58 | ₹8.28 | ₹6.21 |
| EPS - Basic | ₹16.60 | ₹9.17 | ₹6.71 | ₹4.73 |
| EPS - Diluted | ₹16.60 | ₹9.17 | ₹6.71 | ₹4.73 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹34.47 | ₹19.35 | ₹12.01 | ₹9.61 |
| Income before WC changes | ₹35.64 | ₹29.81 | ₹21.80 | ₹13.51 |
| Change in Assets | -₹38.42 | -₹12.08 | -₹13.19 | -₹27.17 |
| Change in Liabilities | ₹28.80 | -₹12.23 | -₹1.70 | ₹21.98 |
| Change in WC | -₹9.63 | -₹24.31 | -₹14.88 | -₹5.19 |
| Cash flow from Operations | ₹17.54 | -₹1.53 | ₹2.59 | ₹5.78 |
| Cash flow from Investing | -₹39.95 | -₹8.16 | ₹7.92 | -₹15.25 |
| Cash flow from Financing | ₹13.24 | ₹8.81 | -₹0.72 | ₹7.03 |
| Total Cash Flow | -₹9.16 | -₹0.88 | ₹9.78 | -₹2.44 |
| Cash (Start of the year) | ₹18.96 | ₹19.85 | ₹10.06 | ₹12.50 |
| Cash (End of the year) | ₹9.80 | ₹18.96 | ₹19.85 | ₹10.06 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹138.87 | ₹94.07 | ₹93.12 | ₹95.74 |
| Current Assets | ₹173.92 | ₹145.99 | ₹126.40 | ₹114.10 |
| Total Assets | ₹312.78 | ₹240.06 | ₹219.52 | ₹209.85 |
| Current Liabilities | ₹84.31 | ₹64.22 | ₹68.87 | ₹69.28 |
| Net Current Asset | ₹89.61 | ₹81.78 | ₹57.53 | ₹44.83 |
| Non-Current Liabilities | ₹28.02 | ₹0.17 | ₹0.07 | ₹0.28 |
| Equity Capital | ₹200.46 | ₹175.67 | ₹150.58 | ₹140.29 |
| Total Equity & Liabilities | ₹312.78 | ₹240.06 | ₹219.52 | ₹209.85 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹181.59 | ₹131.60 | ₹117.78 | ₹105.16 |
| Other Income | ₹13.72 | ₹6.19 | ₹4.60 | ₹4.56 |
| Total Revenue | ₹195.30 | ₹137.79 | ₹122.38 | ₹109.72 |
| Total Expenses | ₹154.61 | ₹114.43 | ₹102.93 | ₹95.79 |
| Profit Before Tax | ₹40.69 | ₹23.35 | ₹19.45 | ₹13.93 |
| Tax | ₹9.53 | ₹5.78 | ₹3.73 | ₹3.40 |
| Profit After Tax | ₹31.16 | ₹17.57 | ₹15.72 | ₹10.53 |
| EPS - Basic | ₹19.37 | ₹11.03 | ₹10.09 | ₹6.76 |
| EPS - Diluted | ₹19.37 | ₹11.03 | ₹10.09 | ₹6.76 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹40.69 | ₹23.35 | ₹19.45 | ₹13.93 |
| Income before WC changes | ₹35.00 | ₹25.22 | ₹21.40 | ₹14.02 |
| Change in Assets | -₹32.83 | -₹18.15 | -₹12.35 | -₹20.25 |
| Change in Liabilities | ₹21.53 | -₹2.61 | ₹1.37 | ₹13.97 |
| Change in WC | -₹11.30 | -₹20.76 | -₹10.97 | -₹6.28 |
| Cash flow from Operations | ₹15.23 | -₹2.58 | ₹6.10 | ₹5.21 |
| Cash flow from Investing | -₹41.42 | -₹8.71 | ₹6.24 | -₹16.08 |
| Cash flow from Financing | ₹15.65 | ₹11.40 | ₹3.04 | ₹7.55 |
| Total Cash Flow | -₹10.54 | ₹0.11 | ₹15.39 | -₹3.32 |
| Cash (Start of the year) | ₹17.95 | ₹17.84 | ₹2.45 | ₹5.77 |
| Cash (End of the year) | ₹7.41 | ₹17.95 | ₹17.84 | ₹2.45 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹195.78 | ₹145.98 | ₹137.65 | ₹134.57 |
| Current Assets | ₹162.38 | ₹141.49 | ₹114.77 | ₹97.72 |
| Total Assets | ₹358.16 | ₹287.47 | ₹252.42 | ₹232.29 |
| Current Liabilities | ₹77.20 | ₹64.37 | ₹56.42 | ₹53.99 |
| Net Current Asset | ₹85.18 | ₹77.11 | ₹58.35 | ₹43.73 |
| Non-Current Liabilities | ₹28.02 | ₹0.17 | ₹0.07 | ₹0.28 |
| Equity Capital | ₹252.94 | ₹222.92 | ₹195.93 | ₹178.03 |
| Total Equity & Liabilities | ₹358.16 | ₹287.47 | ₹252.42 | ₹232.29 |
About KILITCH DRUGS
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
KILITCH DRUGS Financial Highlights
- Revenue: KILITCH DRUGS reported revenue of ₹246.71 crore in FY26 vs ₹209.48 crore in FY25. It showed an increase of 17.77% on a yearly basis.
- Operating Profit: KILITCH DRUGS reported an operating profit of ₹38.65 crore in FY26 vs ₹34.47 crore in FY25. It showed an increase of 12.13% on a year-on-year basis.
- Net Profit: KILITCH DRUGS reported a net profit of ₹29.50 crore in FY26 vs ₹24.94 crore in FY25. It showed an increase of 18.28% on a yearly basis.
KILITCH DRUGS Quarterly Result Highlights
- KILITCH DRUGS reported revenue of ₹90.09 crore in Mar 2026, compared with ₹55.34 crore in Dec 2025, representing an increase of 62.79% on a quarter-on-quarter (QoQ) basis.
- KILITCH DRUGS reported an operating profit of ₹20.21 crore in Mar 2026, compared with ₹5.60 crore in Dec 2025, representing an increase of 260.89% on a quarter-on-quarter (QoQ) basis.
- KILITCH DRUGS reported a profit of ₹14.88 crore in Mar 2026, compared with ₹4.32 crore in Dec 2025, reflecting an increase of 244.44% on a QoQ basis.
- The earnings per share (EPS) of KILITCH DRUGS stood at ₹16.60 during Mar 2026.
Similar Stocks
FAQs on KILITCH DRUGS Share Price
What is KILITCH DRUGS share price today?
KILITCH DRUGS share price is ₹187.50 as on 03 Jul, 2026, 15:27 IST.
How has the KILITCH DRUGS share price performed in the past?
In the last 1 year, KILITCH DRUGS delivered a return of -15.07%. The KILITCH DRUGS share price hit a high of ₹250.00 and low of ₹117.25.
How much is the Mutual Fund shareholding in KILITCH DRUGS shares?
The Mutual Fund Shareholding in KILITCH DRUGS was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of KILITCH DRUGS shares ?
The 52-week high and low of KILITCH DRUGS share is ₹250.00 and ₹117.25 as of 03 Jul, 2026.
What is the market cap of KILITCH DRUGS?
The market capitalisation of KILITCH DRUGS is ₹686.65 Crores as on 03 Jul, 2026.
What are the stock symbols of KILITCH DRUGS?
The stock symbol of KILITCH DRUGS is KILITCH on the NSE, 524500 on the BSE, and the ISIN is INE729D01010.
What was yesterday's closing price of KILITCH DRUGS shares ?
KILITCH DRUGS shares closed yesterday at ₹196.99 on NSE & ₹196.40 on BSE
How to buy KILITCH DRUGS shares?
To buy KILITCH DRUGS shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy KILITCH DRUGS shares on Holidays?
No, shares of KILITCH DRUGS or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell KILITCH DRUGS shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of KILITCH DRUGS?
The PE and PB ratio of KILITCH DRUGS is 23.27 and 2.46 respectively, as on 03 Jul, 2026, 15:27 IST.